Kamada Ltd. (KMDA)
NASDAQ: KMDA · IEX Real-Time Price · USD
5.00
+0.17 (3.52%)
At close: Jul 2, 2024, 4:00 PM
5.10
+0.10 (2.00%)
After-hours: Jul 2, 2024, 6:17 PM EDT
Kamada Revenue
Kamada had revenue of $149.55M in the twelve months ending March 31, 2024, with 13.33% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $37.74M with 22.88% year-over-year growth. In the year 2023, Kamada had annual revenue of $142.52M with 10.19% growth.
Revenue (ttm)
$149.55M
Revenue Growth
+13.33%
P/S Ratio
1.92
Revenue / Employee
$395,622
Employees
378
Market Cap
287.37M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 142.52M | 13.18M | 10.19% |
Dec 31, 2022 | 129.34M | 25.70M | 24.79% |
Dec 31, 2021 | 103.64M | -29.60M | -22.22% |
Dec 31, 2020 | 133.25M | 6.06M | 4.76% |
Dec 31, 2019 | 127.19M | 12.72M | 11.11% |
Dec 31, 2018 | 114.47M | 11.64M | 11.32% |
Dec 31, 2017 | 102.83M | 25.33M | 32.69% |
Dec 31, 2016 | 77.49M | 7.59M | 10.85% |
Dec 31, 2015 | 69.91M | -1.16M | -1.63% |
Dec 31, 2014 | 71.07M | 442.00K | 0.63% |
Dec 31, 2013 | 70.62M | -2.05M | -2.82% |
Dec 31, 2012 | 72.68M | 13.19M | 22.18% |
Dec 31, 2011 | 59.48M | 25.01M | 72.53% |
Dec 31, 2010 | 34.48M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Accolade | 431.53M |
Amarin Corporation | 277.46M |
Zynex | 188.68M |
Alimera Sciences | 90.22M |
Poseida Therapeutics | 82.50M |
Enanta Pharmaceuticals | 72.88M |
XOMA Corporation | 5.81M |
Opthea | 385.28K |
KMDA News
- 7 weeks ago - Kamada Reports Strong First Quarter 2024 Financial Results with Year-Over-Year Top-Line Growth of 23% and a 96% Increase in Profitability; Raises Full-Year Financial Guidance - GlobeNewsWire
- 2 months ago - Kamada to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024 - GlobeNewsWire
- 4 months ago - Kamada Issues 2024 CEO Letter to Shareholders - GlobeNewsWire
- 4 months ago - Kamada Reports Strong Fiscal Year and Fourth Quarter 2023 Financial Results, and Provides Full-Year 2024 Guidance Representing Double-Digit Growth in Revenue and Profitability - GlobeNewsWire
- 4 months ago - Kamada to Announce Fourth Quarter and Fiscal Year 2023 Financial Results, and Provide 2024 Financial Guidance on March 6, 2024 - GlobeNewsWire
- 7 months ago - KEDRION ANNOUNCES AN EIGHT-YEAR EXTENSION OF THE DISTRIBUTION AGREEMENT WITH KAMADA IN THE US FOR KEDRAB® - PRNewsWire
- 7 months ago - Kamada Announces its Largest Commercial Agreement; A Strategic Engagement with Kedrion for U.S. Distribution of KEDRAB® including $180 Million of Revenues Over First Four Years - GlobeNewsWire
- 8 months ago - Kamada Reports Significant Increase in Sales and Profitability in the Third Quarter and Nine Month 2023; Reiterates 2023 Revenue and Profitability Guidance - GlobeNewsWire